PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
17-Nov-2025 The AAMA Installs Jane B. Seelig, CMA-a (AAMA), as 2025-2027 Speaker of the House ACCESS Newswire
17-Nov-2025 MEDHOST Announces General Availability of Enterprise and EDIS 2024 R1 Releases: Advancing Healthcare Interoperability ACCESS Newswire
17-Nov-2025 Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value ACCESS Newswire
17-Nov-2025 AI usage moves from pilot to pillar, claims LogiPharma in new report LogiPharma
17-Nov-2025 D.C. Circuit Grills DEA Over Years Long Delays as MMJ BioPharma Cultivation Demands Timely Ruling on Cannabis Grow ACCESS Newswire
17-Nov-2025 Reason Health Launches ReasonHub to Unlock the Value of Healthcare Knowledge Content ACCESS Newswire
17-Nov-2025 Compassion Center, the Las Vegas Community, and Loved Ones Honor the Life and Immeasurable Legacy of Julie "Nurse Juhlzie" Monteiro with Community Celebrations December 13-14, 2025 ACCESS Newswire
17-Nov-2025 VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year ACCESS Newswire
17-Nov-2025 Dr. Shajira Mohammed Joins Ankle & Foot Centers of America, Serving Emory Midtown and Lithonia Offices ACCESS Newswire
17-Nov-2025 CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update ACCESS Newswire
17-Nov-2025 NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position ACCESS Newswire
17-Nov-2025 Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump ACCESS Newswire
17-Nov-2025 IGC Pharma Reports Accelerated Q2 Progress and Strengthened Financial Focus: CALMA Trial Passes 50% Enrollment Milestone, Strategic Divestiture Optimizes Capital ACCESS Newswire
17-Nov-2025 Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs ACCESS Newswire
17-Nov-2025 Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue ACCESS Newswire
17-Nov-2025 Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin ACCESS Newswire
17-Nov-2025 OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma ACCESS Newswire
17-Nov-2025 Wellgistics Health to Report Third Quarter 2025 Financial Results and Provide a Business Update on the morning of Thursday, November 20th, 2025 ACCESS Newswire
17-Nov-2025 iZafe Group's Business Unit Manager, Helena Kolvik, Acquires Shares in the Company ACCESS Newswire
17-Nov-2025 EMA Positive Opinion for Orphan Drug Designation to BioInvent's BI‑1808 for the Treatment of Cutaneous T-cell Lymphoma ACCESS Newswire